Skip to main content
. 2021 Oct 20;29(4):562–576. doi: 10.5606/tgkdc.dergisi.2021.22121

Recom-. G-5.

National guideline recommendations for the treatment of cancer-related VTE
Recommendation Grade Level of evidence Key references
LMWH is recommended in cases of VTE due to cancer. Very strong recommendation (I) A Kakkos et al.[2]
Ortel et al.[9]
Kirkilesis et al.[23]
Use of DOAC (apixaban*, edoxaban, rivaroxaban) is recommended for the treatment of cancer-related VTE. Very strong recommendation (I) A Kakkos et al.[2] Ortel et al.[9] Kirkilesis et al.[23] Agnelli et al.[27]Ageno et al.[28]
VTE: Venous thromboembolism; LMWH: Low molecular weight heparin; DOAC: Direct oral anticoagulant; * Apixaban may be preferred primarily in carefully selected patients with gastrointestinal system tumors.